Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease

被引:0
作者
Emmanuil S. Hatzipantelis
Zoe Dorothea Pana
N. Gombakis
A. Taparkou
V. Tzimouli
D. Kleta
D. J. Zafeiriou
V. Garipidou
F. Kanakoudi
M. Athanassiou
机构
[1] AHEPA University Hospital,2nd Pediatric Department of Aristotle University of Thessaloniki
[2] Hippokration General Hospital,1st Pediatric Department of Aristotle University of Thessaloniki
[3] Hippokration General Hospital,General Haematology Laboratory
[4] Hippokration General Hospital,2nd Propedeutic Department of Internal Medicine
来源
International Journal of Hematology | 2013年 / 98卷
关键词
Sickle cell disease; Childhood; ET-1; sP-selectin; Endothelial dysfunction;
D O I
暂无
中图分类号
学科分类号
摘要
Sickle cell disease pathogenesis is a complex interplay of multiple factors associated with vascular endothelial activation, intense oxidative stress, and increased sickle cell adhesion. The aim of this study was to determine and compare three panels of plasma circulating biomarkers at ‘steady state’ and during veno-occlusive crises (VOC) in a cohort of children and adolescents with SCD and healthy controls. The following biomarkers were assessed: acute phase reactants, endothelial factors, and adhesion molecules. Forty-one SCD pediatric patients and 28 healthy children were enrolled. Patients at ‘steady state’ presented significantly elevated plasma levels of endothelin-1 (ET-1), soluble-VCAM-1 (sVCAM-1), soluble P-selectin (sP-selectin), and d-dimers compared to the control group. ET-1, sP-selectin, platelet-derived growth factor (PDGF), von Willebrand factor (vWf), d-dimers, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) seems to represent additional, but not independent, prognostic markers of VOC crisis. Elevated plasma levels of sP-selectin, ET-1, and sVCAM-1 were associated with VOC frequency. The present study provides preliminary evidence of a possible association between these biomarkers and the endothelial activation at steady state and VOC in childhood SCD. Further prospective studies are required to confirm the potential independent prognostic value of these markers in different stages of pediatric SCD.
引用
收藏
页码:158 / 163
页数:5
相关论文
共 56 条
  • [11] Steinberg MH(2009)Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease PLoS ONE 4 e7956-625
  • [12] Villagra J(2010)Sickle cell anemia and vascular dysfunction: the nitric oxide connection J Cell Physiol 224 620-837
  • [13] Shiva S(1995)The metabolites of nitric oxide in sickle-cell disease Br J Haematol 91 834-520
  • [14] Hunter LA(2000)Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome J Pediatr Hematol Oncol 22 515-371
  • [15] Haywood LJ(1990)Nitrogen metabolism in sickle cell anemia: free amino acids in plasma and urine Am J Med Sci 300 366-111
  • [16] Krishnan S(2003)Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels Am J Hematol 74 104-1528
  • [17] Setty Y(2008)Sickle cell disease vasculopathy: a state of nitric oxide resistance Free Radic Biol Med. 44 1506-2265
  • [18] Betal SG(2008)Pulmonary complications of sickle cell disease N Engl J Med 359 2254-278
  • [19] Naprawa JT(2012)Lower airway nitric oxide is increased in children with sickle cell disease J Pediatr 160 93-undefined
  • [20] Bonsu BK(2003)Divergent nitric oxide bioavailability in men and women with sickle cell disease Circulation 107 271-undefined